4th Quarter - Report

THE MCMANUS GROUP for AMGEN

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R.9 - Innovation Act & S.1137 - PATENT Act

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1137 (114th), H.R. 9 (114th)

Medicare/Medicaid MMM

Access and reimbursement for Part B drugs. Opposition to the increase in LIS cost sharing in H.R.6 - 21st Century Cures Act

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Health Issues HCR

Regulatory and legislative activities regarding 340B program.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.